Navigation Links
Watson Second Quarter 2011 Net Revenue Exceeds $1 Billion; Non-GAAP EPS of $1.01
Date:7/26/2011

any's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net revenue or income; variability of trade buying patterns; fluctuations in foreign currency exchange rates; changes in generally accepted accounting principles; risks that the carrying values of assets may be negatively impacted by future events and circumstances; the timing and success of product launches; the difficulty of predicting the timing or outcome of product development efforts and FDA or other regulatory agency approvals or actions; the uncertainty associated with the identification and successful consummation of external business development transactions; market acceptance of and continued demand for Watson's products; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson's and its third party manufacturers' facilities, products and/or businesses; changes in the laws and regulations, including Medicare, Medicaid, and similar laws in foreign countries affecting, among other things, pricing and reimbursement of pharmaceutical products and the settlement of patent litigation; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's annual report on Form 10-K for the period ended December 31, 2010 and Watson's quarterly report on Form 10-Q for the period ended March 31, 2011. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.  

All trademarks are the property of their respective owners.  

The following table presents Watson's results of operations for the three and six months ended June 30, 2011 and 2010:

Table 1WATSON PHARMACEUTICALS, INC.CONDENSED CONSOLIDATED STATEME
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Watson Confirms JALYN™ Patent Challenge
2. Watson Confirms Favorable Appeals Court Decision in Mucinex(R) Patent Suit
3. Watson Confirms Vyvanse® Patent Challenge
4. Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings
5. Watson Announces Expansion of Salt Lake City, Utah Pharmaceutical R&D and Manufacturing Facility
6. Watson to Present at 2011 Wells Fargo Securities Healthcare Conference
7. Watson Confirms AVODART(R) Patent Challenge
8. Watson Confirms Court Decision Rejecting Tevas Motion to Prevent Launch of Generic SEASONIQUE®
9. Watsons Nabumetone Tablets Receive FDA Approval
10. Watson Confirms Pataday™ Patent Challenge
11. Watson Confirms Viagra® Patent Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
(Date:10/17/2014)... Oct. 17, 2014 A victim of medical negligence ... doctor with a history of alcohol abuse, a physician ... on Prop 46 today, highlighting how Prop 46 will identify ... testing. The ad pictures a doctor drinking ... To ER."  Proposition 46 will enact the first law in ...
(Date:10/17/2014)...  Talyst, a market leader in pharmacy automation will ... Nashville, TN. The company will ... for onsite, remote medication dispensing. Talyst,s ... and securely dispense medication onsite, on demand. Remote dispensing ... that the correct medication gets to the correct patient ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4Talyst Exhibits at LeadingAge Annual Meeting 2
... 13, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... third quarter of 2010 on Wednesday, October 20, 2010 at ... and chief executive officer, will lead the call. On the ... third quarter of 2010.   The call will ...
... Following recent FDA approvals for prostate cancer treatment ... the lives of men with advanced prostate cancer ... from Johnson & Johnson. The drug, which could reach the ... with the potential to change clinical practice by providing ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Third Quarter Results 2Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2
(Date:10/20/2014)... MA (PRWEB) October 20, 2014 ... sponsoring a booth at the American Foundation for Suicide ... 25th. The AFSP is a not-for-profit organization that hosts ... Net proceeds from these events are used to help ... but education and personal relationships as well. , ...
(Date:10/20/2014)... October 20, 2014 hc1.com today ... secure cloud solution that enables healthcare organizations of ... ultimate healthcare-specific customer relationship management (“CRM”) solution. , ... unique needs of the healthcare industry, the hc1 ... providers and patients by combining healthcare CRM, HIPAA-compliant ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Principle Business ... takes pride in manufacturing top-of-the-line absorbent products. The ... of its most popular brand, Tranquility® Premium Protection absorbent ... a new website, gave its packaging a new look, ... the brand message to the public. , The new ...
(Date:10/20/2014)... 2014 Succeed is proud to announce that ... participated in the Every Body Walk! campaign by ... project that encourages workers to be more active outside of ... which concluded at the end of September, was a friendly ... metro areas. Participating companies gave their staff pedometers and ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... FORT LAUDERDALE, Fla., Dec. 10 Synovics,Pharmaceuticals, Inc. (OTC ... further reduction of its debt by paying off the,last ... the sale of,additional Series C Convertible Redeemable Preferred Stock ... As previously reported in the ...
... MIAMI, Dec. 10 Todobebe, Inc., a leading ... today the roll out,of its website property "embarazo.com", ... URL in 1999, and the new site reinforces ... trusted,content for Spanish speaking families globally. , ...
... LLC (Prime),announces that it has been chosen by Blue ... pharmacy benefit management services, beginning,January 1, 2009. , ... benefit services to more than 175,000 BCBSMT,members enrolled in ... covers a range of pharmacy benefit services including:,claims processing, ...
... to drive again , , WEDNESDAY, Dec. 10 (HealthDay News) -- ... after orthopedic surgery or injury, but knowing when it,s safe to ... surgeons weigh in on the issue in the December issue of ... "Deciding when a patient can return to driving is a difficult ...
... density, new analysis shows , , WEDNESDAY, Dec. 10 (HealthDay ... Actos, double the risk of fractures in women but ... Avandia (rosiglitazone) and Actos (pioglitazone) are used to lower ... studies have suggested that the risk for heart failure, ...
... Artist Toni Braxton and Her Son Featured in TV and ... YORK, Dec. 10 The Advertising Council, in partnership with ... of public service advertisements (PSAs) featuring Grammy award-winning recording artist ... about autism and to urge parents to learn the early ...
Cached Medicine News:Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 2Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 3Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 4Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 5Health News:Todobebe Rolls Out Embarazo.com for Pregnant Moms 2Health News:Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client 2Health News:Returning to the Road Tricky After Injury 2Health News:2 Diabetes Drugs Double Fracture Risk in Women 2Health News:2 Diabetes Drugs Double Fracture Risk in Women 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 4
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large devices for vascular intervention....
Used to introduce balloon, closed and non-tapered end catheters and other devices for intervention....
Medicine Products: